SEC 13F Intelligence

Birchview Capital, LP / ARRYEUR

Birchview Capital, LP’s Array Biopharma Inc Position

Does Birchview Capital, LP own Array Biopharma Inc (ARRYEUR)? Not currently — the last reported position was 168.0K shares worth $8M in Q2 2019; the fund’s latest 13F (Q1 2026) no longer reports it.

Position Value
$8M
Q2 2019
Shares
168.0K
% of Portfolio
+4.73%
Quarters Held
3
position exited

Position History ARRYEUR

Reported value by quarter
Q4 ’18: $2MQ4 ’18Q1 ’19: $4MQ1 ’19Q2 ’19: $8MQ2 ’19filingsflow.com
QuarterSharesValue% of Portfolio
Q2 2019168.0K$8M+4.73%
Q1 2019168.0K$4M+2.57%
Q4 2018168.0K$2M+2.26%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Birchview Capital, LP’s full portfolio or all institutional holders of ARRYEUR.